Hepatocellular carcinoma (HCC) is among the most common cancerous growths, and therapeutic options are limited in late-stage patients. The high fatality rate is mainly attributed to metastatic progression. Tumor invasion and metastasis are significantly influenced by matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9.